Originally published by our sister publication Infectious Disease Special Edition
By Norah Chinn and Marie Rosenthal, MS
The Advisory Committee on Immunization Practices (ACIP) said the high-dose inactivated (HD-IIV3) and adjuvanted inactivated (allV3) influenza vaccines are acceptable options for vaccinating solid-organ transplant (SOT) recipients ages 18 to 64 years against influenza.
Before this change, this recommendation was only made for SOT patients who were 65 and older.
During the past